Advertisement
Screener

CYPHERPUNK TECHNOLOGIES INC. (CYPH) Basic Shares Outstanding (Weighted Average)

CYPHERPUNK TECHNOLOGIES INC. Basic Shares Outstanding (Weighted Average)

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Basic Shares Outstanding (Weighted Average) of 184.33 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12

  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 184.33M shares, a 344.75% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 168.10M shares, a 307.34% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 140.40M shares, a 240.13% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 41.44M shares, a 0.57% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2025 was 66.14M shares, a 76.14% increase from fiscal 2024.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2024 was 37.55M shares, a 83.67% increase from fiscal 2023.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2023 was 20.45M shares, a 80.55% increase from fiscal 2022.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2022 was 11.32M shares, a 86.81% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-30184.33M shares
10-Q · filed 2026-08-12
176.26M shares
10-Q · filed 2026-08-12
164.28M shares
derived: average of 3 quarters · filed 2026-08-12
133.57M shares
derived: average of 4 quarters · filed 2026-08-12
2026-03-31168.10M shares
10-Q · filed 2026-05-14
154.25M shares
derived: average of 2 quarters · filed 2026-05-14
116.65M shares
derived: average of 3 quarters · filed 2026-05-14
97.85M shares
derived: average of 4 quarters · filed 2026-08-12
2025-12-31140.40M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
90.92M shares
derived: average of 2 quarters · filed 2026-03-16
74.43M shares
derived: average of 3 quarters · filed 2026-08-12
66.14M shares
10-K · filed 2026-03-16
2025-09-3041.44M shares
10-Q · filed 2025-11-12
41.44M shares
derived: average of 2 quarters · filed 2026-08-12
41.39M shares
10-Q · filed 2025-11-12
41.36M shares
derived: average of 4 quarters · filed 2026-08-12
2025-06-3041.44M shares
10-Q · filed 2026-08-12
41.36M shares
10-Q · filed 2026-08-12
41.33M shares
derived: average of 3 quarters · filed 2026-08-12
41.30M shares
derived: average of 4 quarters · filed 2026-08-12
2025-03-3141.27M shares
10-Q · filed 2026-05-14
41.27M shares
derived: average of 2 quarters · filed 2026-05-14
41.25M shares
derived: average of 3 quarters · filed 2026-05-14
40.72M shares
derived: average of 4 quarters · filed 2026-05-14
2024-12-3141.28M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
41.24M shares
derived: average of 2 quarters · filed 2026-03-16
40.54M shares
derived: average of 3 quarters · filed 2026-03-16
37.55M shares
10-K · filed 2026-03-16
2024-09-3041.21M shares
10-Q · filed 2025-11-12
40.17M shares
derived: average of 2 quarters · filed 2025-11-12
36.31M shares
10-Q · filed 2025-11-12
33.60M shares
derived: average of 4 quarters · filed 2025-11-12
2024-06-3039.12M shares
10-Q · filed 2025-08-14
33.83M shares
10-Q · filed 2025-08-14
31.07M shares
derived: average of 3 quarters · filed 2025-08-14
30.05M shares
derived: average of 4 quarters · filed 2025-08-14
2024-03-3127.01M shares
10-Q · filed 2025-05-13
27.04M shares
derived: average of 2 quarters · filed 2025-05-13
27.02M shares
derived: average of 3 quarters · filed 2025-05-13
23.94M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-3127.06M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
27.02M shares
derived: average of 2 quarters · filed 2025-03-26
22.92M shares
derived: average of 3 quarters · filed 2025-03-26
20.45M shares
10-K · filed 2025-03-26
2023-09-3026.99M shares
10-Q · filed 2024-11-13
20.85M shares
derived: average of 2 quarters · filed 2024-11-13
18.24M shares
10-Q · filed 2024-11-13
16.49M shares
derived: average of 4 quarters · filed 2024-11-13
2023-06-3014.71M shares
10-Q · filed 2024-08-12
13.79M shares
10-Q · filed 2024-08-12
12.99M shares
derived: average of 3 quarters · filed 2024-08-12
12.57M shares
derived: average of 4 quarters · filed 2024-08-12
2023-03-3112.93M shares
10-Q · filed 2024-05-13
129.34M shares
10-Q · filed 2023-05-15
12.13M shares
derived: average of 2 quarters · filed 2024-05-13
11.86M shares
derived: average of 3 quarters · filed 2024-05-13
11.73M shares
derived: average of 4 quarters · filed 2024-05-13
2022-12-3111.32M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
11.32M shares
derived: average of 2 quarters · filed 2024-03-18
11.32M shares
derived: average of 3 quarters · filed 2024-03-18
11.32M shares
10-K · filed 2024-03-18
113.24M shares
10-K · filed 2023-03-24
2022-09-3011.32M shares
10-Q · filed 2023-11-13
113.24M shares
10-Q · filed 2022-11-14
11.32M shares
derived: average of 2 quarters · filed 2023-11-13
11.32M shares
10-Q · filed 2023-11-13
113.24M shares
10-Q · filed 2022-11-14
62.33M shares
derived: average of 4 quarters · filed 2023-11-13
2022-06-3011.32M shares
10-Q · filed 2023-08-14
113.25M shares
10-Q · filed 2022-08-12
11.32M shares
10-Q · filed 2023-08-14
113.25M shares
10-Q · filed 2022-08-12
79.33M shares
derived: average of 3 quarters · filed 2023-08-14
79.05M shares
derived: average of 4 quarters · filed 2023-08-14
2022-03-31113.25M shares
10-Q · filed 2023-05-15
113.33M shares
derived: average of 2 quarters · filed 2023-05-15
101.63M shares
derived: average of 3 quarters · filed 2023-05-15
95.32M shares
derived: average of 4 quarters · filed 2023-05-15
2021-12-31113.41M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
95.81M shares
derived: average of 2 quarters · filed 2023-03-24
89.34M shares
derived: average of 3 quarters · filed 2023-03-24
85.83M shares
10-K · filed 2023-03-24
2021-09-3078.22M shares
10-Q · filed 2022-11-14
77.30M shares
derived: average of 2 quarters · filed 2022-11-14
76.63M shares
10-Q · filed 2022-11-14
76.91M shares
derived: average of 4 quarters · filed 2022-11-14
2021-06-3076.39M shares
10-Q · filed 2022-08-12
76.38M shares
10-Q · filed 2022-08-12
76.48M shares
derived: average of 3 quarters · filed 2022-08-12
76.44M shares
derived: average of 4 quarters · filed 2022-08-12
2021-03-3176.38M shares
10-Q · filed 2022-05-13
76.52M shares
derived: average of 2 quarters · filed 2022-05-13
76.45M shares
derived: average of 3 quarters · filed 2022-05-13
70.45M shares
derived: average of 4 quarters · filed 2022-05-13
2020-12-3176.66M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
76.49M shares
derived: average of 2 quarters · filed 2022-03-11
68.48M shares
derived: average of 3 quarters · filed 2022-03-11
59.33M shares
10-K · filed 2022-03-11
2020-09-3076.32M shares
10-Q · filed 2020-11-12
64.38M shares
derived: average of 2 quarters · filed 2020-11-12
53.55M shares
10-Q · filed 2020-11-12
46.15M shares
derived: average of 4 quarters · filed 2021-03-12
2020-06-3052.44M shares
10-Q · filed 2020-08-13
42.04M shares
10-Q · filed 2020-08-13
36.10M shares
derived: average of 3 quarters · filed 2021-03-12
33.05M shares
derived: average of 4 quarters · filed 2021-03-12
2020-03-3131.63M shares
10-Q · filed 2020-05-14
27.92M shares
derived: average of 2 quarters · filed 2021-03-12
26.59M shares
derived: average of 3 quarters · filed 2021-03-12
25.67M shares
derived: average of 4 quarters · filed 2021-03-12
2019-12-3124.21M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
24.07M shares
derived: average of 2 quarters · filed 2021-03-12
23.68M shares
derived: average of 3 quarters · filed 2021-03-12
22.58M shares
10-K · filed 2021-03-12
2019-09-3023.92M shares
10-Q · filed 2020-11-12
23.41M shares
derived: average of 2 quarters · filed 2020-11-12
22.04M shares
10-Q · filed 2020-11-12
20.19M shares
derived: average of 4 quarters · filed 2020-11-12
2019-06-3022.91M shares
10-Q · filed 2020-08-13
21.08M shares
10-Q · filed 2020-08-13
18.95M shares
derived: average of 3 quarters · filed 2020-08-13
17.89M shares
derived: average of 4 quarters · filed 2020-08-13
2019-03-3119.24M shares
10-Q · filed 2020-05-14
16.97M shares
derived: average of 2 quarters · filed 2020-05-14
16.22M shares
derived: average of 3 quarters · filed 2020-05-14
2018-12-3114.71M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
14.71M shares
derived: average of 2 quarters · filed 2020-03-16
14.14M shares
10-K · filed 2020-03-16
2018-09-3014.70M shares
10-Q · filed 2019-11-14
13.96M shares
10-Q · filed 2019-11-14
2017-12-3110.89M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
10.14M shares
derived: average of 2 quarters · filed 2019-04-01
9.16M shares
10-K · filed 2019-04-01
2017-09-309.40M shares
10-Q · filed 2018-11-09
8.58M shares
10-Q · filed 2018-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06